The Community Guide

- gsearch

Search Results

Narrow Results:

2021 1
2020 2
2019 2
2015 2
2012 1

HPV-IMPACT Working Group 5

Journal Article 8

1 - 8 of 8 Results

Refine Results

Refine Results:

SARS-CoV-2 in Nursing Homes after 3 Months of Serial, Facilitywide Point Prevalence Testing, Connecticut, USA

CITE Title : SARS-CoV-2 in Nursing Homes after 3 Months of Serial, Facilitywide Point Prevalence Testing, Connecticut, USA Personal Author(s) : Ehrlich, Hanna Y.;Harizaj, Adora;Campbell, Lauren;Colt, McKenzie;Yuan, Karen;Rabatsky-Ehr, Therese;Weinberger, Daniel M.;Leung, Vivian;Niccolai, Linda M.;Parikh, Sunil; Published Date : May 2021 Source : Emerg Infect Dis. 27(5):1288-1295 URL : https://stacks.cdc.gov/view/cdc/106035 Ehrlich, Hanna Y. et al. (2021). SARS-CoV-2 in Nursing Homes after 3 Months of Serial, Facilitywide Point Prevalence Testing, Connecticut, USA. 27(5). Ehrlich, Hanna Y. et al. "SARS-CoV-2 in Nursing Homes after 3 Months of Serial, Facilitywide Point Prevalence Testing, Connecticut, USA" 27, no. 5 (2021) Ehrlich, Hanna Y. et al. "SARS-CoV-2 in Nursing Homes after 3 Months of Serial, Facilitywide Point Prevalence Testing, Connecticut, USA" vol. 27, no. 5, 2021 Export RIS Citation Information.

:

Ehrlich, Hanna Y. ;

Harizaj, Adora

May 2021 | Emerg Infect Dis. 27(5):1288-1295

:

Nursing homes house populations that are highly vulnerable to coronavirus disease. Point prevalence surveys (PPSs) provide information on the severe a...
Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18

CITE Title : Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18 Personal Author(s) : Johnson Jones, Michelle L.;Gargano, Julia Warner;Powell, Melissa;Park, Ina U.;Niccolai, Linda M.;Bennett, Nancy M.;Griffin, Marie R.;Querec, Troy;Unger, Elizabeth R.;Markowitz, Lauri E.; Corporate Authors(s) : HPV-IMPACT Working Group Published Date : 4 02 2020;4-02-; Source : Am J Epidemiol. 189(4):265-276 URL : https://stacks.cdc.gov/view/cdc/115080 Johnson Jones, Michelle L. et al. (2020). Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18. 189(4). Johnson Jones, Michelle L. et al. "Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18" 189, no. 4 (2020) Johnson Jones, Michelle L. et al. "Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18" vol. 189, no. 4, 2020 Export RIS Citation Information.

:

Johnson Jones, Michelle L. ;

Gargano, Julia Warner

4 02 2020 | Am J Epidemiol. 189(4):265-276

:

Before 2016, human papillomavirus (HPV) vaccination was recommended on a 3-dose schedule. However, many vaccine-eligible US females received fewer tha...
Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008–2014

CITE Title : Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008–2014 Personal Author(s) : McClung, Nancy M.;Gargano, Julia W.;Bennett, Nancy M.;Niccolai, Linda M.;Abdullah, Nasreen;Griffin, Marie R.;Park, Ina U.;Cleveland, Angela A.;Querec, Troy D.;Unger, Elizabeth R.;Markowitz, Lauri E.; Corporate Authors(s) : HPV-IMPACT Working Group Published Date : February 21 2019 Source : Cancer Epidemiol Biomarkers Prev. 28(3):602-609 URL : https://stacks.cdc.gov/view/cdc/78649 McClung, Nancy M. et al. (2019). Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008–2014. 28(3). McClung, Nancy M. et al. "Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008–2014" 28, no. 3 (2019) McClung, Nancy M. et al. "Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008–2014" vol. 28, no. 3, 2019 Export RIS Citation Information.

:

McClung, Nancy M. ;

Gargano, Julia W.

February 21 2019 | Cancer Epidemiol Biomarkers Prev. 28(3):602-609

:

Background:The impact of human papillomavirus (HPV) vaccination has been observed in the United States through declining cervical precancer incidence ...
Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008–2012

CITE Title : Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008–2012 Personal Author(s) : Hariri, Susan;Markowitz, Lauri E.;Bennett, Nancy M.;Niccolai, Linda M.;Schafer, Sean;Bloch, Karen;Park, Ina U.;Scahill, Mary W.;Julian, Pamela;Abdullah, Nasreen;Levine, Diane;Whitney, Erin;Unger, Elizabeth R.;Steinau, Martin;Bauer, Heidi M.;Meek, James;Hadler, James;Sosa, Lynn;Powell, Suzanne E.;Johnson, Michelle L.;Group, HPV-IMPACT Working; Published Date : Sep 2015 Source : Emerg Infect Dis. 21(9):1557-1561 URL : https://stacks.cdc.gov/view/cdc/33140 Hariri, Susan et al. (2015). Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008–2012. 21(9). Hariri, Susan et al. "Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008–2012" 21, no. 9 (2015) Hariri, Susan et al. "Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008–2012" vol. 21, no. 9, 2015 Export RIS Citation Information.

:

Hariri, Susan ;

Markowitz, Lauri E.

Sep 2015 | Emerg Infect Dis. 21(9):1557-1561

:

In 2007, five Emerging Infections Program (EIP) sites were funded to determine the feasibility of establishing a population-based surveillance system ...
Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012☆

CITE Title : Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012☆ Personal Author(s) : Hariri, Susan;Bennett, Nancy M.;Niccolai, Linda M.;Schafer, Sean;Park, Ina U.;Bloch, Karen C.;Unger, Elizabeth R.;Whitney, Erin;Julian, Pamela;Scahill, Mary W.;Abdullah, Nasreen;Levine, Diane;Johnson, Michelle L.;Steinau, Martin;Markowitz, Lauri E.; Published Date : February 11 2015 Source : Vaccine. 33(13):1608-1613 URL : https://stacks.cdc.gov/view/cdc/94604 Hariri, Susan et al. (2015). Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012☆. 33(13). Hariri, Susan et al. "Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012☆" 33, no. 13 (2015) Hariri, Susan et al. "Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012☆" vol. 33, no. 13, 2015 Export RIS Citation Information.

:

Hariri, Susan ;

Bennett, Nancy M.

February 11 2015 | Vaccine. 33(13):1608-1613

:

Background:Prevention of pre-invasive cervical lesions is an important benefit of HPV vaccines, but demonstrating impact on these lesions is impeded b...
Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008–2015

CITE Title : Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008–2015 Personal Author(s) : Cleveland, Angela A.;Gargano, Julia W.;Park, Ina U.;Griffin, Marie R.;Niccolai, Linda M.;Powell, Melissa;Bennett, Nancy M.;Saadeh, Kayla;Pemmaraju, Manideepthi;Higgins, Kyle;Ehlers, Sara;Scahill, Mary;Jones, Michelle L. Johnson;Querec, Troy;Markowitz, Lauri E.;Unger, Elizabeth R.; Corporate Authors(s) : HPV-IMPACT Working Group Published Date : 2 01 2020;2-01-; Source : Int J Cancer. 146(3):810-818 URL : https://stacks.cdc.gov/view/cdc/117627 Cleveland, Angela A. et al. (2020). Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008–2015. 146(3). Cleveland, Angela A. et al. "Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008–2015" 146, no. 3 (2020) Cleveland, Angela A. et al. "Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008–2015" vol. 146, no. 3, 2020 Export RIS Citation Information.

:

Cleveland, Angela A.

;

Gargano, Julia W.

2 01 2020 | Int J Cancer. 146(3):810-818

:

Primary prevention through the use of human papillomavirus (HPV) vaccination is expected to impact both cervical intraepithelial neoplasia (CIN) and a...
Human Papillomavirus Genotypes in High-Grade Cervical Lesions in the United States

CITE Title : Human Papillomavirus Genotypes in High-Grade Cervical Lesions in the United States Personal Author(s) : Hariri, Susan;Unger, Elizabeth R.;Powell, Suzanne E.;Bauer, Heidi M.;Bennett, Nancy M.;Bloch, Karen C.;Niccolai, Linda M.;Schafer, Sean;Steinau, Martin;Markowitz, Lauri E.; Corporate Authors(s) : HPV-IMPACT Working Group Published Date : October 08 2012 Source : J Infect Dis. 206(12):1878-1886 URL : https://stacks.cdc.gov/view/cdc/94040 Hariri, Susan et al. (2012). Human Papillomavirus Genotypes in High-Grade Cervical Lesions in the United States. 206(12). Hariri, Susan et al. "Human Papillomavirus Genotypes in High-Grade Cervical Lesions in the United States" 206, no. 12 (2012) Hariri, Susan et al. "Human Papillomavirus Genotypes in High-Grade Cervical Lesions in the United States" vol. 206, no. 12, 2012 Export RIS Citation Information.

:

Hariri, Susan ;

Unger, Elizabeth R.

October 08 2012 | J Infect Dis. 206(12):1878-1886

:

Background.Two vaccines protect against human papillomaviruses (HPV) 16 and 18, which cause 70% of cervical cancer and 50% of cervical intraepithelial...
Estimated Number of Cases of High-Grade Cervical Lesions Diagnosed Among Women — United States, 2008 and 2016

CITE Title : Estimated Number of Cases of High-Grade Cervical Lesions Diagnosed Among Women — United States, 2008 and 2016 Personal Author(s) : McClung, Nancy M.;Gargano, Julia W.;Park, Ina U.;Whitney, Erin;Abdullah, Nasreen;Ehlers, Sara;Bennett, Nancy M.;Scahill, Mary;Niccolai, Linda M.;Brackney, Monica;Griffin, Marie R.;Pemmaraju, Manideepthi;Querec, Troy D.;Cleveland, Angela A.;Unger, Elizabeth R.;Markowitz, Lauri E.;Blankenship, Sheelah;Allen, Stephanie;Meek, James;Higgins, Kyle;Hadler, James;Sosa, Lynn;Saadeh, Kayla;Fink, Deana;Silverberg, Michael;Powell, Melissa E.;Allain, Shannon Q.;Felsen, Christina;Bogart, RaeAnne;Feiler, Marina Oktapodas;Dahl, Rebecca M.; Corporate Authors(s) : HPV-IMPACT Working Group Published Date : April 19 2019 Pages in Document : 7 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR Morbidity Mortal Weekly Rep. 68(15):337-343 DOI : http://dx.doi.org/10.15585/mmwr.mm6815a1 Journal Title : Morbidity and Mortality Weekly Report (MMWR) McClung, Nancy M. et al. (2019). Estimated Number of Cases of High-Grade Cervical Lesions Diagnosed Among Women — United States, 2008 and 2016. 68(15). http://dx.doi.org/10.15585/mmwr.mm6815a1 McClung, Nancy M. et al. "Estimated Number of Cases of High-Grade Cervical Lesions Diagnosed Among Women — United States, 2008 and 2016" 68, no. 15 (2019), http://dx.doi.org/10.15585/mmwr.mm6815a1 McClung, Nancy M. et al. "Estimated Number of Cases of High-Grade Cervical Lesions Diagnosed Among Women — United States, 2008 and 2016" vol. 68, no. 15, 2019, http://dx.doi.org/10.15585/mmwr.mm6815a1 Export RIS Citation Information.

:

McClung, Nancy M. ;

Gargano, Julia W.

April 19 2019 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Human papillomaVirus (HPV) causes approximately 30,000 cancers in the United States annually (1). HPV vaccination was introduced in 2006 to prevent HP...